Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells
Authors Li X, Pei B, Wang H, Tang C, Zhu W, Jin F
Received 19 December 2017
Accepted for publication 5 March 2018
Published 6 June 2018 Volume 2018:11 Pages 3359—3368
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Ingrid Espinoza
Xueqing Li,1,* Bing Pei,2,* Hui Wang,1 Chenghui Tang,1 Wei Zhu,3,4 Feng Jin5
1Department of General Surgery, The Fifth People’s Hospital of Shanghai Fudan University, Shanghai, People’s Republic of China; 2Clinical Laboratory, Suqian First Hospital, Suqian, People’s Republic of China; 3Department of Anesthesia, Jiangsu People’s Hospital, Nanjing, People’s Republic of China; 4Department of Anesthesia, Suqian First Hospital, Suqian, People’s Republic of China; 5Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People’s Republic of China
*These authors contributed equally to this work
Objectives: Based on the functionality of AQP-5 characterized in various physiological processes, our study aimed to investigate the effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells.
Materials and methods: The expression levels of AQP-5 mRNA in different experimental groups were measured by reverse transcription PCR. The chemosensitivity of the cells to adriamycin (ADR) was detected by a CCK-8 kit. Cell invasion, migration, and apoptosis were assessed. Western blot was used to detect the expression levels of AQP-5, drug resistance-related protein, and apoptosis-related protein.
Results: The expression level of AQP-5 in MCF-7/ADR cells was significantly reduced by AQP-5 siRNA transfection. The invasion and migration were significantly reduced in MCF-7/ADR after AQP-5 siRNA interference. AQP-5 silencing significantly increased the chemosensitivity of MCF-7/ADR cells to ADR and activated caspase-dependent apoptosis in MCF-7/ADR cells. AQP-5 silencing also decreased the expression levels of drug resistance-related proteins (P-gp and GST-Π).
Conclusion: The inhibition of AQP-5 expression may reverse the drug resistance and enhance the chemosensitivity of breast cancer cells.
Keywords: aquaporin 5, breast cancer, ADR, chemosensitivity, apoptosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]